BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 25698065)

  • 1. Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.
    Pierorazio PM; Johnson MH; Ball MW; Gorin MA; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME
    Eur Urol; 2015 Sep; 68(3):408-15. PubMed ID: 25698065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re: Five-Year Analysis of a Multi-Institutional Prospective Clinical Trial of Delayed Intervention and Surveillance for Small Renal Masses: The DISSRM Registry.
    Laguna MP
    J Urol; 2016 Feb; 195(2):297-8. PubMed ID: 26852966
    [No Abstract]   [Full Text] [Related]  

  • 3. Kidney cancer: Surveillance not inferior in SRM.
    Thoma C
    Nat Rev Urol; 2015 Apr; 12(4):178. PubMed ID: 25732860
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of small renal mass: an opportunity to address a growing problem in early stage kidney cancer.
    Jewett MA; Richard PO; Finelli A
    Eur Urol; 2015 Sep; 68(3):416-7. PubMed ID: 26004796
    [No Abstract]   [Full Text] [Related]  

  • 5. Active surveillance of small renal masses offers short-term oncological efficacy equivalent to radical and partial nephrectomy.
    Patel N; Cranston D; Akhtar MZ; George C; Jones A; Leiblich A; Protheroe A; Sullivan M
    BJU Int; 2012 Nov; 110(9):1270-5. PubMed ID: 22564495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selecting Patients with Small Renal Masses for Active Surveillance: A Domain Based Score from a Prospective Cohort Study.
    Sotimehin AE; Patel HD; Alam R; Gorin MA; Johnson MH; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
    J Urol; 2019 May; 201(5):886-892. PubMed ID: 30694934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Approach to the small renal mass: to treat or not to treat.
    Kim SP; Thompson RH
    Urol Clin North Am; 2012 May; 39(2):171-9, vi. PubMed ID: 22487760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observation should be considered as an alternative in management of renal masses in older and comorbid patients.
    Beisland C; Hjelle KM; Reisaeter LA; Bostad L
    Eur Urol; 2009 Jun; 55(6):1419-27. PubMed ID: 19147267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.
    Mason RJ; Abdolell M; Trottier G; Pringle C; Lawen JG; Bell DG; Jewett MA; Klotz L; Rendon RA
    Eur Urol; 2011 May; 59(5):863-7. PubMed ID: 21353376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.
    Alam R; Patel HD; Osumah T; Srivastava A; Gorin MA; Johnson MH; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
    BJU Int; 2019 Jan; 123(1):42-50. PubMed ID: 30019484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry.
    Uzosike AC; Patel HD; Alam R; Schwen ZR; Gupta M; Gorin MA; Johnson MH; Gausepohl H; Riffon MF; Trock BJ; Chang P; Wagner AA; McKiernan JM; Allaf ME; Pierorazio PM
    J Urol; 2018 Mar; 199(3):641-648. PubMed ID: 28951284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Prospective, Comparative Study of Quality of Life among Patients with Small Renal Masses Choosing Active Surveillance and Primary Intervention.
    Patel HD; Riffon MF; Joice GA; Johnson MH; Chang P; Wagner AA; McKiernan JM; Trock BJ; Allaf ME; Pierorazio PM
    J Urol; 2016 Nov; 196(5):1356-1362. PubMed ID: 27140071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active Surveillance is Superior to Radical Nephrectomy and Equivalent to Partial Nephrectomy for Preserving Renal Function in Patients with Small Renal Masses: Results from the DISSRM Registry.
    Danzig MR; Ghandour RA; Chang P; Wagner AA; Pierorazio PM; Allaf ME; McKiernan JM
    J Urol; 2015 Oct; 194(4):903-9. PubMed ID: 25813449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.
    McIntosh AG; Ristau BT; Ruth K; Jennings R; Ross E; Smaldone MC; Chen DYT; Viterbo R; Greenberg RE; Kutikov A; Uzzo RG
    Eur Urol; 2018 Aug; 74(2):157-164. PubMed ID: 29625756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Active Surveillance for Young Patients with Small Renal Masses: Prospective Data from the DISSRM Registry.
    Metcalf MR; Cheaib JG; Biles MJ; Patel HD; Peña VN; Chang P; Wagner AA; McKiernan JM; Pierorazio PM
    J Urol; 2021 May; 205(5):1286-1293. PubMed ID: 33356478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
    Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
    Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overall survival and development of stage IV chronic kidney disease in patients undergoing partial and radical nephrectomy for benign renal tumors.
    Kaushik D; Kim SP; Childs MA; Lohse CM; Costello BA; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2013 Oct; 64(4):600-6. PubMed ID: 23280319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of renal functional decline in patients undergoing surveillance in the DISSRM registry.
    Castañeda CV; Danzig MR; Finkelstein JB; RoyChoudhury A; Wagner AA; Chang P; Pierorazio PM; Allaf ME; McKiernan JM
    Urol Oncol; 2015 Apr; 33(4):166.e17-20. PubMed ID: 25601768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.